Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.64B P/E - EPS this Y -63.90% Ern Qtrly Grth -
Income -54.37M Forward P/E -18.93 EPS next Y 61.00% 50D Avg Chg -2.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 7.00%
Dividend N/A Price/Book 5.89 EPS next 5Y - 52W High Chg -22.00%
Recommedations 1.60 Quick Ratio 32.53 Shares Outstanding 80.98M 52W Low Chg 252.00%
Insider Own 4.28% ROA -14.64% Shares Float 440.24M Beta 0.42
Inst Own 85.25% ROE -22.67% Shares Shorted/Prior 6.40M/6.69M Price 20.64
Gross Margin - Profit Margin - Avg. Volume 394,422 Target Price 33.14
Oper. Margin - Earnings Date May 7 Volume 185,167 Change -3.80%
About Verona Pharma plc

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Verona Pharma plc News
03/04/24 Andrew Fisher Joins Verona Pharma as General Counsel
03/01/24 Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
03/01/24 3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
06:36 AM Verona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results
02:00 AM Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
02/25/24 When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?
02/15/24 Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
02/01/24 Michael Austwick Joins Verona Pharma as Non-Executive Director
01/15/24 Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures
01/03/24 Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference
01/02/24 Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
12/30/23 3 Stocks That Could Be Monster Winners in 2024
12/26/23 Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day
12/22/23 3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024
11/23/23 Wall Street Analysts Believe Verona Pharma PLC American Depositary Share (VRNA) Could Rally 135.87%: Here's is How to Trade
11/17/23 Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award
11/14/23 11 Best Undervalued UK Stocks To Buy Now
11/08/23 Verona Pharma Announces November 2023 Investor Conference Participation
11/07/23 Does Verona Pharma PLC American Depositary Share (VRNA) Have the Potential to Rally 119.18% as Wall Street Analysts Expect?
11/05/23 Verona Pharma plc (NASDAQ:VRNA) Q3 2023 Earnings Call Transcript
VRNA Chatroom

User Image Bull4ZOM Posted - 8 hours ago

$VRNA $DRCT $XPON .I'd stick with DRCT for now, specially at sub 15. Float is so low, DRCT is a swing traders paradise!

User Image Homebody1 Posted - 10 hours ago

$VRNA Had to add here @ $15.86. Couldn't resist...

User Image Rungreen Posted - 12 hours ago

$VRNA RSI dropping again and we may see another round of $15 before reversing, going into earnings. Time will tell, but it ain’t talking!

User Image badprecog Posted - 15 hours ago

$VRNA Not going to be greedy, lets close over $16.75 today... we need to get closer to $20 before the traders move in seeking to make the money on the approval.

User Image Jakeipedia Posted - 15 hours ago

$VRNA small add here. Great value

User Image badprecog Posted - 16 hours ago

$VRNA Seems like they like to kick us in the head first thing in the morning.

User Image AndyBStonks Posted - 17 hours ago

$XPON like this post if you think Expion is going to CRUSH their first earnings call today! $DRCT $VRNA

User Image Rungreen Posted - 18 hours ago

$VRNA —RSI now 50.70!

User Image GMFoods Posted - 18 hours ago

$VRNA More funds seem to be investing here recently: 3 days ago: Legato Capital Management Today: American Century Companies Building to better days

User Image AIALuckyDog Posted - 1 day ago

$VRNA Wait, I haven’t made my goal of 40k shares (and I’ve been averaging UP) LOL!!😜Real fun starts around first blue line when this officially breaks out and gets the attention of traders IMO. Additionally, when we get the (elusive) golden cross it’ll alert all sorts of scanners. seems like SI is relatively unchanged (~6.4M) compared w/2/29 and slightly down compared to 2/15 numbers. Managed to close above VWAP today, steadily making higher lows and that’s what we want (slow ascension) as more/more shorts begin to cover. Let’s keep this party rockin’💃🏻🤙🕺

User Image BeyondtheCouch Posted - 1 day ago

$VRNA added

User Image marked0ne Posted - 1 day ago

$VRNA aaaaand bought again.

User Image Blink182rulez Posted - 1 day ago

$VRNA

User Image badprecog Posted - 1 day ago

$VRNA Come on Verona just asking for another green day!

User Image badprecog Posted - 1 day ago

$VRNA I think 2 more weeks and then the speculators start to buy. Better it be funds... but I think it is coming soon.

User Image Trainguy1 Posted - 1 day ago

$VRNA It looks like VRNA's SP is rising. The only question is by how much?

User Image AIALuckyDog Posted - 2 days ago

$VRNA

User Image AIALuckyDog Posted - 2 days ago

Race to $20 update: $RNA still in first w/ $GLSI closing in very quickly although $VRNA (finally) showing some signs of life as of late as it heads into PDUFA. All 3 bios w/exceptional leadership and BO targets w/solid science/data. all three also worth holding long IMO. GLTALs

User Image Blink182rulez Posted - 2 days ago

$VRNA

User Image badprecog Posted - 2 days ago

$VRNA 2 months out when we pickup the traders?

User Image Ruff22 Posted - 2 days ago

$VRNA Today - MAX 3 months out til PDUFA date! Time for this one to build some positive momentum.

User Image badprecog Posted - 3 days ago

$VRNA Day started off good before suckdome set in.

User Image Trainguy1 Posted - 3 days ago

$VRNA $30 target looks feasible according to the analysts.

User Image AIALuckyDog Posted - 3 days ago

$VRNA This thing hits $30+ and it’ll be my (slightly) unconventional baby “milli” bio😂👻💰Let her run MMs, not going anywhere🤌

User Image Blink182rulez Posted - 3 days ago

$VRNA

User Image Rungreen Posted - 3 days ago

$VRNA Green all the way!

User Image CashRacks Posted - 4 days ago

$VRNA Headed to $20

User Image BigErvy Posted - 5 days ago

$VRNA

User Image marked0ne Posted - 6 days ago

$VRNA THIS is the share distribution you should worry about!

User Image PoeDallas Posted - 6 days ago

$VRNA added 50 more today.

Analyst Ratings
HC Wainwright & Co. Buy Mar 4, 24
Wedbush Outperform Mar 1, 24
HC Wainwright & Co. Buy Jan 22, 24
HC Wainwright & Co. Buy Dec 29, 23
HC Wainwright & Co. Buy Sep 11, 23
Canaccord Genuity Buy Sep 1, 23
HC Wainwright & Co. Buy Aug 4, 23
Wedbush Outperform Jun 28, 23
Truist Securities Buy Jun 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Feb 01 Sell 2.22 36,248 80,471 2,731,624 02/05/24
Edwards Martin Director Director Nov 20 Buy 1.8370 33,736 61,973 144,800 11/22/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Nov 01 Sell 1.92 58,752 112,804 2,840,640 11/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Aug 03 Sell 2.51 80,144 201,161 2,872,528 08/07/23
ZACCARDELLI DAVID President and CEO President and CEO Aug 03 Sell 2.5 275,888 689,720 16,431,800 08/07/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 03 Sell 2.5 275,888 689,720 15,521,248 08/07/23
Poll Claire General Counsel General Counsel Aug 03 Sell 2.5 48,472 121,180 1,907,367 08/07/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 01 Sell 2.64 179,648 474,271 15,797,136 08/03/23
Poll Claire General Counsel General Counsel Aug 01 Sell 2.64 31,552 83,297 1,955,839 08/03/23
ZACCARDELLI DAVID President and CEO President and CEO Aug 01 Sell 2.64 179,648 474,271 16,707,688 08/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Aug 01 Sell 2.64 33,464 88,345 2,952,672 08/03/23
ORBIMED ADVISORS LLC Director Director May 11 Sell 21.47 482,913 10,368,142 3,777,778 05/15/23
Gupta Rishi Director Director May 11 Sell 21.47 482,913 10,368,142 3,777,778 05/15/23
Poll Claire General Counsel General Counsel May 01 Sell 2.5759 80,376 207,041 1,979,063 05/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer May 01 Sell 2.61 106,176 277,119 2,971,136 05/03/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer May 01 Sell 2.5759 455,528 1,173,395 15,976,784 05/03/23
ZACCARDELLI DAVID President and CEO President and CEO May 01 Sell 2.5759 455,536 1,173,415 16,887,336 05/03/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 2.5572 413,168 1,056,553 16,432,312 02/03/23
ZACCARDELLI DAVID President and CEO President and CEO Feb 01 Sell 2.5572 432,928 1,107,083 17,342,872 02/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Jan 20 Sell 2.54 118,712 301,528 3,077,312 02/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Jan 20 Option 0 105,000 3,196,024 02/03/23
Poll Claire General Counsel General Counsel Jan 20 Sell 2.59 152,000 393,680 774,256 02/03/23
Poll Claire General Counsel General Counsel Jan 20 Option 0 178,800 2,211,439 02/03/23
Poll Claire General Counsel General Counsel Nov 21 Sell 2.69 240,000 645,600 774,256 12/27/22
ORBIMED ADVISORS LLC Director Director Dec 22 Sell 22.68 6,139,864 139,252,116 34,085,528 12/27/22
Gupta Rishi Director Director Dec 22 Sell 22.68 6,139,864 139,252,116 34,085,528 12/27/22
ZACCARDELLI DAVID President and CEO President and CEO Aug 09 Sell 1.75 600,000 1,050,000 15,263,560 08/11/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 09 Sell 1.75 600,000 1,050,000 14,313,496 08/11/22
ZACCARDELLI DAVID President and CEO President and CEO May 03 Sell 0.4956 32,904 16,307 16,351,328 05/05/22
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer May 03 Sell 0.4923 28,752 14,155 2,461,224 05/05/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer May 03 Sell 0.4956 12,512 6,201 15,381,520 05/05/22
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Apr 08 Sell 0.56 172,520 96,611 2,546,408 04/12/22
Deschamps Lisa Director Director Feb 01 Sell 0.7775 11,664 9,069 70,320 02/03/22
ZACCARDELLI DAVID President and CEO President and CEO Feb 01 Sell 0.73 52,056 38,001 16,839,096 02/03/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 0.76 10,416 7,916 15,826,160 02/03/22
ZACCARDELLI DAVID President and CEO President and CEO Nov 01 Sell 0.64 52,056 33,316 16,845,352 11/03/21
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Nov 01 Sell 0.65 10,416 6,770 15,991,120 11/03/21